Cedars-Sinai Medical Center

Cedars-Sinai Medical Center was paid $69.99M by Medicaid between Jan 2018 and Dec 2024, across 528 billing codes. Its largest line is 0450, Emergency room services — 15% of everything it billed.

33Billing provider infoCEDARS-SINAI MEDICAL CENTER
LOS ANGELES, CA 90048

33aNPI1639172372assigned 05/26/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$69.99M

24GClaims1,377,474

24DCodes billed528

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#39 of 410

Median peer was paid$6.90M

This provider vs. median10×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	220,477	$11.25M
2019	201,964	$12.14M
2020	162,626	$13.85M
2021	164,269	$8.23M
2022	165,151	$8.31M
2023	192,770	$9.18M
2024incomplete	270,217	$7.03M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	15%	55,416	50,598	$10.63M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.8%	33,974	31,333	$2.69M
80053	Comprehensive metabolic panel	3.4%	33,648	26,627	$2.36M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	2.8%	29,492	26,955	$1.98M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.8%	82,720	70,319	$1.98M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	2.4%	25,967	23,732	$1.67M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.3%	6,488	6,323	$1.62M
78815	Positron emission tomography (PET) for limited area imaging	2.3%	1,617	1,590	$1.58M
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	2.0%	915	472	$1.43M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	1.9%	18,065	6,355	$1.34M
J0485	Injection, belatacept, 1 mg	1.8%	1,774	1,620	$1.25M
74183		1.8%	2,294	2,250	$1.25M

516 more codes

0710		1.7%	3,820	$1.16M
80048	Basic metabolic panel (calcium, ionized)	1.6%	55,805	$1.11M
A0429	Emergency ambulance ride, basic life support	1.5%	1,134	$1.03M
99283	Emergency room visit (moderate)	1.2%	10,765	$864K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.2%	35,574	$846K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	1.1%	3,084	$800K
87496		1.1%	2,182	$788K
70450	Computed tomography, head or brain; without contrast material	1.1%	5,623	$755K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.1%	8,562	$739K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	3,003	$690K
J3262	Injection, tocilizumab, 1 mg	<1%	634	$656K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,661	$652K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	5,026	$631K
99232	Hospital visit by a doctor, follow-up day	<1%	18,917	$623K
96375	Therapeutic injection; each additional sequential IV push	<1%	13,403	$617K
83735		<1%	17,461	$597K
71250		<1%	4,995	$585K
94375		<1%	3,977	$561K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	17,364	$525K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	107,399	$514K
93970		<1%	16,951	$507K
86832		<1%	3,213	$498K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	12,631	$498K
86833		<1%	3,268	$490K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	12,869	$478K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,431	$462K
0270		<1%	5,323	$441K
71046	Radiologic examination, chest; 2 views	<1%	8,684	$440K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,979	$433K
86900		<1%	5,414	$428K
J3490	Unclassified drugs	<1%	14,076	$424K
G0378	Hospital observation service, per hour	<1%	2,229	$410K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,300	$406K
93454		<1%	1,069	$405K
99214	Doctor's office visit, returning patient (more involved)	<1%	12,820	$398K
87497		<1%	1,547	$386K
84100		<1%	13,877	$386K
99213	Doctor's office visit, returning patient (routine)	<1%	6,548	$380K
71045	Radiologic examination, chest; single view	<1%	12,760	$372K
86850		<1%	4,810	$367K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,983	$352K
0250		<1%	13,527	$351K
80197		<1%	12,292	$303K
86975		<1%	4,490	$303K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,838	$295K
0761		<1%	3,135	$291K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,365	$271K
Q3014	Telehealth originating site facility fee	<1%	14,714	$268K
87799		<1%	1,606	$258K
99215	Doctor's office visit, returning patient (complex)	<1%	6,469	$257K
86901		<1%	5,364	$248K
0510		<1%	14,101	$237K
94726		<1%	1,629	$233K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	12,933	$231K
80076		<1%	19,025	$229K
99223	Prolong inpt eval add15 m	<1%	3,318	$224K
81001		<1%	27,129	$217K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,747	$215K
0760		<1%	6,788	$205K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,557	$200K
0272		<1%	4,230	$199K
99203	Doctor's office visit, new patient (routine)	<1%	2,166	$185K
Z7500		<1%	5,157	$175K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	6,266	$175K
75574		<1%	1,912	$171K
80061	Lipid panel	<1%	8,736	$166K
93505		<1%	118	$163K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,805	$161K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,807	$158K
96376		<1%	2,763	$156K
72197		<1%	801	$156K
99222	Initial hospital care, per day, moderate complexity	<1%	2,986	$151K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	4,861	$148K
96361	Intravenous infusion, hydration; each additional hour	<1%	4,540	$147K
J0897	Injection, denosumab, 1 mg	<1%	291	$145K
85610		<1%	10,455	$144K
96415		<1%	1,632	$143K
93325		<1%	5,386	$142K
87088		<1%	7,521	$141K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	7,005	$136K
93971		<1%	4,191	$135K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,250	$133K
82784		<1%	2,582	$132K
83880		<1%	7,890	$132K
83615		<1%	3,453	$130K
C1769	Guide wire	<1%	862	$119K
93880		<1%	2,603	$117K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,564	$117K
0370		<1%	1,853	$117K
74174		<1%	410	$114K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	2,131	$113K
94729		<1%	1,847	$112K
87040		<1%	3,279	$109K
38222		<1%	161	$107K
84484		<1%	11,270	$101K
88185		<1%	77	$96K
78812		<1%	307	$93K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,041	$89K
J2704	Injection, propofol, 10 mg	<1%	3,390	$89K
A9581	Injection, gadoxetate disodium, 1 ml	<1%	925	$88K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	32	$87K
J7030	Infusion, normal saline solution , 1000 cc	<1%	5,310	$87K
82803		<1%	467	$86K
72141		<1%	517	$84K
83690		<1%	10,191	$83K
99199	Unlisted special service, procedure or report	<1%	3,070	$80K
93312		<1%	1,167	$79K
88341		<1%	380	$79K
78492		<1%	156	$79K
93975		<1%	656	$77K
A9585	Injection, gadobutrol, 0.1 ml	<1%	3,334	$75K
85730		<1%	6,925	$75K
73502		<1%	912	$74K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	3,791	$72K
93308		<1%	4,198	$70K
82565		<1%	4,575	$68K
99221		<1%	1,913	$68K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	6,272	$66K
94200		<1%	1,447	$64K
99204	Doctor's office visit, new patient (more involved)	<1%	1,781	$63K
J9310	Injection, rituximab, 100 mg	<1%	29	$63K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,364	$62K
83605		<1%	4,129	$62K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,194	$62K
99205	Prolong outpt/office vis	<1%	1,481	$62K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	390	$59K
84703		<1%	5,928	$58K
88342		<1%	688	$58K
99238	Hospital discharge day management, 30 minutes or less	<1%	1,140	$56K
77080		<1%	1,249	$55K
Z7502		<1%	1,447	$54K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	134	$52K
36556		<1%	932	$51K
84550		<1%	3,778	$51K
J1644	Injection, heparin sodium, per 1000 units	<1%	3,865	$51K
A4649	Surgical supply; miscellaneous	<1%	121	$50K
76830	Ultrasound, transvaginal	<1%	1,270	$49K
92928		<1%	186	$49K
84443	Thyroid stimulating hormone (TSH)	<1%	8,031	$49K
76937		<1%	1,515	$48K
77066	Tomosynthesis, mammo	<1%	1,331	$48K
82378		<1%	2,418	$47K
82728		<1%	3,538	$47K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	6,758	$46K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,462	$46K
73562		<1%	1,872	$46K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	7,936	$45K
72131		<1%	416	$44K
87186		<1%	2,640	$44K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,203	$43K
91065		<1%	363	$43K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	431	$42K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,787	$42K
93922		<1%	2,401	$39K
31624		<1%	297	$38K
73030		<1%	1,520	$37K
87340		<1%	1,199	$37K
82550		<1%	1,931	$36K
73610		<1%	1,478	$36K
94010		<1%	245	$36K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	238	$36K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	257	$35K
93451		<1%	31	$35K
94618		<1%	472	$35K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	913	$34K
77334		<1%	339	$33K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	2,842	$33K
93321		<1%	5,301	$32K
92978		<1%	72	$32K
82570		<1%	3,874	$32K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,998	$32K
87070		<1%	1,611	$31K
86803		<1%	1,645	$31K
49083		<1%	363	$31K
0301		<1%	935	$30K
73630		<1%	1,428	$30K
J1170	Injection, hydromorphone, up to 4 mg	<1%	2,768	$30K
99292		<1%	798	$30K
88184		<1%	159	$29K
85027		<1%	5,106	$29K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	506	$29K
86480		<1%	493	$28K
76642		<1%	1,310	$28K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,466	$28K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,448	$28K
83036	Hemoglobin; glycosylated (A1C)	<1%	7,248	$27K
81370		<1%	29	$27K
0002A		<1%	771	$27K
32555		<1%	697	$27K
99239	Hospital discharge day management, more than 30 minutes	<1%	584	$27K
84156		<1%	2,553	$27K
70496		<1%	102	$26K
31623		<1%	14	$26K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	168	$25K
72100		<1%	962	$25K
70491		<1%	149	$25K
43264		<1%	66	$25K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,372	$24K
86140		<1%	4,740	$24K
93320		<1%	279	$24K
20610		<1%	1,199	$24K
87077		<1%	5,201	$24K
0001A		<1%	687	$24K
86592		<1%	471	$24K
93017		<1%	745	$23K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	982	$22K
72170		<1%	664	$22K
70486		<1%	253	$22K
87522	Neg quan hep c or qual rna	<1%	191	$22K
88307		<1%	143	$22K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,917	$22K
93923		<1%	716	$21K
85379		<1%	2,027	$21K
0949		<1%	582	$21K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,422	$21K
86923		<1%	192	$20K
36415	Collection of venous blood by venipuncture	<1%	5,486	$20K
0160		<1%	453	$20K
Z9726		<1%	440	$19K
73130		<1%	920	$19K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	4,502	$19K
90715		<1%	794	$19K
J2785	Injection, regadenoson, 0.1 mg	<1%	560	$18K
93296		<1%	842	$18K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	488	$18K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,842	$18K
88350		<1%	85	$18K
83550		<1%	4,265	$18K
83540		<1%	4,604	$18K
76770		<1%	353	$17K
82962		<1%	929	$17K
86930		<1%	71	$17K
87517		<1%	207	$17K
96367		<1%	445	$16K
70498		<1%	72	$16K
77065	Tomosynthesis, mammo	<1%	557	$15K
J9312	Injection, rituximab, 10 mg	<1%	14	$15K
83883		<1%	546	$15K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,981	$15K
99254		<1%	206	$15K
82607		<1%	2,539	$15K
0305		<1%	659	$14K
73110		<1%	549	$14K
87205		<1%	1,576	$14K
93458		<1%	50	$14K
96116		<1%	336	$14K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,802	$14K
97162		<1%	508	$14K
85652		<1%	4,323	$13K
93925		<1%	830	$13K
99070		<1%	40	$13K
87536		<1%	167	$13K
86300		<1%	1,583	$13K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	873	$13K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	489	$13K
74181		<1%	12	$13K
87400		<1%	1,052	$12K
73590		<1%	738	$12K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	308	$12K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,106	$12K
76942		<1%	155	$11K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,924	$11K
99152		<1%	438	$11K
77300		<1%	76	$10K
83970		<1%	1,116	$10K
84702		<1%	784	$10K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,003	$10K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	654	$10K
76376		<1%	514	$9K
0306		<1%	321	$9K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	15	$9K
0511		<1%	1,453	$9K
80306		<1%	909	$8K
99253		<1%	99	$8K
88313		<1%	72	$8K
86704		<1%	464	$8K
0271		<1%	1,400	$8K
36600		<1%	78	$8K
86706		<1%	503	$8K
82746		<1%	1,337	$7K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	916	$7K
88346		<1%	63	$7K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,135	$7K
87081		<1%	1,246	$7K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	360	$7K
J2060	Injection, lorazepam, 2 mg	<1%	1,125	$6K
0004A		<1%	154	$6K
76536		<1%	249	$6K
95720		<1%	75	$6K
93990		<1%	242	$6K
81376		<1%	18	$6K
0762		<1%	244	$6K
81025		<1%	384	$6K
73560		<1%	485	$6K
99443		<1%	97	$6K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	931	$5K
86039		<1%	623	$5K
72040		<1%	178	$5K
93926		<1%	174	$5K
73221		<1%	67	$5K
73700		<1%	58	$5K
84165		<1%	84	$5K
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	<1%	18	$5K
0324		<1%	267	$5K
73564		<1%	181	$5K
96130		<1%	158	$5K
77290		<1%	41	$4K
84439		<1%	1,714	$4K
31500		<1%	101	$4K
84153		<1%	854	$4K
99255		<1%	43	$4K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	500	$4K
96417		<1%	358	$4K
76604		<1%	256	$4K
0637		<1%	837	$4K
97161		<1%	122	$4K
95951		<1%	43	$4K
72110		<1%	298	$4K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	88	$4K
86830		<1%	56	$4K
0300		<1%	388	$4K
86780		<1%	461	$4K
36430		<1%	29	$4K
86831		<1%	56	$4K
0403		<1%	25	$4K
93319		<1%	246	$3K
93798		<1%	43	$3K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	480	$3K
73552		<1%	142	$3K
J2780	Injection, ranitidine hydrochloride, 25 mg	<1%	326	$3K
86352		<1%	98	$3K
0031A		<1%	77	$3K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,055	$3K
77263		<1%	79	$3K
80320		<1%	345	$3K
74160		<1%	14	$3K
75572		<1%	12	$3K
90656		<1%	178	$3K
62270		<1%	28	$3K
93280		<1%	198	$3K
89051		<1%	579	$3K
85007		<1%	513	$3K
73080		<1%	102	$2K
86334		<1%	12	$2K
82105		<1%	226	$2K
87505		<1%	87	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	315	$2K
Z9725		<1%	54	$2K
31628		<1%	26	$2K
82330		<1%	235	$2K
82043		<1%	1,352	$2K
88188		<1%	30	$2K
86235		<1%	449	$2K
84436		<1%	763	$2K
0401		<1%	398	$2K
J7507	Tacrolimus, immediate release, oral, 1 mg	<1%	191	$2K
93978		<1%	34	$2K
85347		<1%	47	$2K
83521		<1%	737	$2K
85014		<1%	194	$2K
84132		<1%	126	$2K
0352		<1%	25	$2K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	85	$2K
82375		<1%	17	$2K
J7999	Compounded drug, not otherwise classified	<1%	28	$2K
90686		<1%	113	$2K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	14	$2K
96132		<1%	42	$2K
99252		<1%	35	$2K
91200		<1%	42	$2K
36620		<1%	96	$2K
93355		<1%	52	$2K
87116		<1%	18	$2K
85651		<1%	450	$2K
93247		<1%	68	$1K
96131		<1%	106	$1K
78306		<1%	28	$1K
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	226	$1K
87420		<1%	67	$1K
0298T		<1%	122	$1K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	153	$1K
80158		<1%	48	$1K
87102		<1%	48	$1K
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	<1%	48	$1K
92611		<1%	59	$1K
97010		<1%	720	$1K
85046		<1%	340	$1K
84481		<1%	281	$1K
0003A		<1%	31	$1K
0258		<1%	76	$1K
86790		<1%	150	$1K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	47	$1K
93294		<1%	115	$1K
77014		<1%	111	$1K
0054A		<1%	28	$1K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	233	$1K
86769		<1%	26	$1K
82150		<1%	194	$1K
72070		<1%	18	$1K
82947		<1%	132	$1K
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	<1%	297	$1K
84520		<1%	146	$989.64
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	28	$986.59
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	349	$955.45
74018		<1%	57	$939.31
99442		<1%	25	$868.55
77063	Screening digital breast tomosynthesis, bilateral	<1%	427	$859.17
86431		<1%	237	$856.51
72158		<1%	12	$846.53
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	198	$832.31
74230		<1%	60	$825.13
86359		<1%	18	$797.72
97116		<1%	100	$791.31
12001		<1%	15	$776.99
87210		<1%	74	$749.10
84479		<1%	160	$744.27
72082		<1%	85	$727.80
J1756	Injection, iron sucrose, 1 mg	<1%	31	$723.42
81003		<1%	255	$722.28
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	<1%	288	$701.96
12011		<1%	13	$682.35
0071A		<1%	17	$680.00
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	54	$645.35
0072A		<1%	16	$640.00
72128		<1%	26	$637.02
93246		<1%	51	$602.48
0730		<1%	129	$582.67
93248		<1%	126	$524.01
74328		<1%	41	$487.07
J3370	Injection, vancomycin hcl, 500 mg	<1%	63	$478.89
0320		<1%	32	$470.37
0360		<1%	222	$456.17
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	123	$433.77
74022		<1%	41	$431.23
80047		<1%	27	$428.94
87480		<1%	182	$428.64
87510		<1%	182	$428.64
93979		<1%	26	$425.07
93279		<1%	32	$385.79
87660		<1%	182	$350.37
82232		<1%	321	$339.33
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	125	$321.81
J7517	Mycophenolate mofetil, oral, 250 mg	<1%	40	$318.90
87015		<1%	39	$287.28
75571		<1%	24	$250.66
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	79	$248.19
76377		<1%	124	$248.13
86160		<1%	391	$244.03
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	12	$242.98
76801		<1%	15	$239.20
86301		<1%	152	$233.81
84295		<1%	28	$225.74
86360		<1%	15	$205.70
82652		<1%	13	$200.72
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	155	$199.94
96121		<1%	16	$196.44
77280		<1%	14	$195.49
82310		<1%	219	$194.56
86787		<1%	13	$187.88
82977		<1%	12	$187.48
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	15	$185.40
73521		<1%	43	$175.39
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	39	$175.09
97166		<1%	17	$166.29
82533		<1%	146	$165.78
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	44	$161.68
87206		<1%	17	$159.76
86225		<1%	272	$158.37
73090		<1%	16	$146.07
J1630	Injection, haloperidol, up to 5 mg	<1%	35	$144.68
94060		<1%	13	$144.12
0780		<1%	220	$140.30
77081		<1%	43	$136.37
73060		<1%	15	$135.05
G0008	Administration of influenza virus vaccine	<1%	27	$134.39
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	335	$128.57
0309		<1%	161	$123.95
88142		<1%	148	$115.40
97802		<1%	13	$97.12
86376		<1%	123	$91.36
J2305	Injection, nitroglycerin, 5 mg	<1%	103	$85.14
80349		<1%	56	$75.74
72050		<1%	25	$71.07
84402		<1%	43	$69.74
86200		<1%	128	$59.84
0636		<1%	45	$51.24
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	29	$50.87
J1171	Injection, hydromorphone, 0.1 mg	<1%	43	$50.85
83721		<1%	197	$49.04
84403		<1%	204	$48.56
83010		<1%	85	$47.77
J0780	Injection, prochlorperazine, up to 10 mg	<1%	15	$37.30
86141		<1%	48	$34.81
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	44	$34.64
82274		<1%	174	$32.97
J3480	Injection, potassium chloride, per 2 meq	<1%	14	$31.89
80324		<1%	40	$25.07
80359		<1%	40	$25.03
84300		<1%	44	$24.49
82435		<1%	15	$20.57
84154		<1%	12	$18.02
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	165	$17.94
82374		<1%	14	$14.73
83921		<1%	26	$13.24
83951		<1%	39	$12.05
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	78	$10.42
82107		<1%	25	$9.93
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	39	$0.20
S9445	Patient education, not otherwise classified, non-physician provider, individual, per session	0%	54	$0.00
0307		0%	13	$0.00
0120		0%	12	$0.00
0302		0%	174	$0.00
J7643	Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram	0%	13	$0.00
86765		0%	12	$0.00
86709		0%	14	$0.00
74178		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLISA, MAQUERIA (VP, CHIEF REV CYCLE OFFICER)